Erika Belmont, MD

Erika Belmont, MD

Hometown: Urbana, IL
Medical School: Rosalind Franklin University 
Residency: University of Chicago
Research/Academic Interests: GI cancers, clinical trials, circulating tumor DNA, precision medicine
Bio: Reading, hiking, board games, traveling, trying new restaurants, hanging out with my two cats! 

Selected Publications/Abstracts

  • Belmont E, Bansal VV, Yousef MMG, Zeineddine MA, Su D, Dhiman A, Liao CY, Polite B, Eng, OS, Fournier KF, White MG, Turaga KK, Shen JP, Shergill A. Multi-Institutional study evaluating the role of circulating tumor DNA in the management of appendiceal cancers. JCO Precision Oncology. May 2024; 8:e2300531. doi: 10.1200/PO.23.00531. PMID: 38723230
  • Bansal VV, Belmont E, Godley FA IV, Dhiman A, Witmer HDD, Li S, Liao A, Eng OS, Turaga KK, Shergill A. Utility of circulating tumor DNA assessment in characterizing recurrence sites after optimal resection for metastatic colorectal cancer. Journal of American College of Surgeons. Jun 2024; 238 (6):1013-1020. doi: 10.1097/XCS.0000000000001028. PMID: 38299640.
  • He G, Belmont E, Karrison T, Stock W, LaBelle JL, Kosuri S, Larson RA, Kline JP, Riedell PA, Nawas M, Bishop MR, Liu H. FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients. Annals of Translational Medicine. Jun 2024; 12(3):49. doi: 10.21037/atm-23-1941
  • Belmont E, Paydary K, Liao CY, Polite B, Kindler HL, Setia N, Shergill A. Outcomes in high-grade neuroendocrine carcinomas (HG-NEC) of the gastrointestinal (GI) tract with modern therapies. Journal of Clinical Oncology. 2022;40(16_suppl):e15609-e15609. doi:10.1200/JCO.2022.40.16_suppl.e15609
  • Gujarathi R, Belmont E, Rodman C, Bansal VV, Setia N, Alpert L, Hart J, Moller M, Eng OS, Lee G, Chin J, Amin MA, Polite B, Liao CY, Turaga K, Shergill A. Early-onset appendiceal adenocarcinoma (EOAA): 10-year experience from a single center. Journal of Clinical Oncology. 2024; 42 (suppl 16_4178-4178). doi:10.1200/JCO.2024.42.16_suppl.4178
  • Gujarathi R, Rodman C, Bansal VV, Belmont E, Setia N, Alpert L, Hart J, Moller M, Eng OS, Lee G, Chin J, Amin MA, Polite B, Liao CY, Turaga K, Shergill A. Association between activating GNAS mutations and outcomes with chemotherapy in metastatic appendiceal adenocarcinoma. Journal of Clinical Oncology. 2024; 42 (suppl 16_4179- 4179). doi:10.1200/JCO.2024.42.16_suppl.4179
  • Meyer AR, Engevik AC, Madorsky T, Belmont E, Stier MT, Pilkinton MA, McDonnel WJ, Mallal SA, Peebles RS, Goldenring JR. Group II innate lymphoid cells (ILC2s) coordinate damage response in the stomach. Gastroenterology. Dec 2020; 159(6):2077-2091.e8. doi:10/10153/j.gastro.2020.08.051. PMID: 32891625.